Latest news with #RamsayHealth
ABC News
a day ago
- Health
- ABC News
Clients 'disgusted and appalled' by Ramsay Health Care psychology clinic shutdowns
Defence veteran Kate* has battled mental illness for more than a decade, at one point even attempting to take her own life. "I sort of hit rock bottom two and a half years ago again. I asked for help this time, which was good, and I've been getting help ever since with Ramsay," she said. "My psychologist gets me like no one else does." Kate was making significant progress before she received news from her therapist that her local Ramsay Psychology clinic would close at the end of August. Kate's psychologist told her Ramsay Health wanted to transition patients to telehealth appointments. "It feels like [Ramsay Health] didn't want [our psychologists] to tell us so that when we did find out, we would have no choice but to stay with them doing telehealth … instead of allowing our psychologist to work with us to sort something else out beforehand," she said. Last week, the ABC revealed Ramsay Health Care would close 17 of its 20 psychology clinics within weeks, citing concerns like rising costs and uneven demand. A briefing note sent to staff said Ramsay Health Care was "exploring the merits" of expanding its existing psychology telehealth services. The ABC has spoken to multiple psychologists employed at Ramsay Psychology clinics who did not want to be identified because they are not authorised to speak publicly. They said staff were "left completely in the dark" about the decision to close the clinics, describing the company's communication to staff as "appalling" and "shambolic". They also claim there were "zero warning signs" the clinics they worked at were about to close and that they were initially instructed not to communicate the planned closures to some of their patients and were given little time to plan. "It's heartbreaking to see our clients left out there in the community with no support," one psychologist told the ABC. "We have clients who have been attending our clinics for years and a lot of them have come out of sessions crying, because the psychologist told them that they will no longer be seen by them. "We will have to find a space to see these vulnerable clients and sometimes they are just not easy to find." Psychologists said they were told their contracts would be ending, but they might be able to pick up telehealth sessions, however it was unclear what that model would look like. Ramsay Health Care is Australia's largest private hospital operator, and its psychology clinics treat a range of high-risk patients with various mental health conditions, including young children, for conditions like depression or PTSD. The provider also runs a separate network of mental health clinics, however they will not be affected by the change. The President of the Australian Psychological Society, Dr Sara Quinn, said the closure of Ramsay Health's psychology clinics across multiple states would have a big impact on its patients. "When a local psychological service closes, it doesn't just remove that place for these people to go, it removes that trusted pathway into care for those who are most vulnerable," she said. "A closure forces people to start again with a new clinician if they're able to find one. And that can, for some people, involve retelling incredibly traumatic and difficult histories, navigating systems that they've never navigated before. "It can then lead to people falling through the cracks." Dr Quinn said clients with the most acute needs would be disproportionately affected. "The clinics that have been closed are closely connected to hospital mental health systems," she said. "People on psychiatry wait lists or those recently discharged from hospital are going to then lose critical follow-up care at the very moment they're potentially most at risk. "So instead of stabilising there, they're left in limbo and we know that many will deteriorate or even end up back in emergency or relapse to the point of needing another hospital admission," she said. Dr Quinn said the clinic closures have also sent shock waves through the profession. "Without urgent reform, closures like this are going to become more common and even more Australians will miss out on the mental health care they need and deserve." One week after Kate learned her local clinic was closing, she received an email from Ramsay Psychology confirming it would shut its doors at the end of August and offer clients telehealth sessions instead. Kate will be able to continue seeing her psychologist in person at another clinic but she said if that was not the case, she would have been "scrambling to find another one" because "there's no way I would have continued with Ramsay." In a statement, Ramsay Health Care said it, "has been working closely with psychologists and other stakeholders to ensure a safe and considered transition for clients impacted". The provider also said it had asked "psychologists to communicate directly with their clients and support them to continue care — either through our expanded telehealth services or with another trusted provider" and that "clients are being informed as part of this process". *Name has been changed to protect identity.
Perth Now
18-06-2025
- Health
- Perth Now
Staff failed to properly check on new mum before death
Hospital staff failed to properly check on a new mum in the grips of postpartum psychosis, but her suicide may not have been preventable, a coroner has found. Sarah Skillington was last seen alive by her husband at 10.27pm as he left her room at the perinatal unit in the Ramsay Health Care-owned Mitcham Private Hospital, in Melbourne's east, on November 18, 2023. The 33-year-old was discovered unresponsive more than 10 hours later and declared dead. Coroner David Ryan found the overnight nurse did not conduct hourly observations as required and it appeared a "culture" had developed among some night-shift staff that meant checks were not done appropriately. A suicide note was found at her home in the days after her death and the coroner said the message was likely written before she was admitted to hospital. "I am unable to conclude that Sarah's death could have been prevented had she been appropriately observed overnight and in the morning on 19 November 2023," he said in his findings on Wednesday. "Even if hourly observations had been performed, Sarah would still have had an opportunity to take her life in the intervening periods." He noted Ms Skillington would not have been able to take her own life if the design of her room was different, an issue the hospital had since addressed. A nurse who worked on the morning the 33-year-old was found dead concluded crumpled bed clothes might have been mistaken for Ms Skillington's sleeping body. The new mother had a difficult birth, experienced anxiety in the days after the delivery and suffered sleeplessness, the court heard. She previously had disordered eating, health anxiety and reported "fleeting suicidal ideation". Ms Skillington said she was exhausted when admitted to hospital and the coroner noted the overnight nurse wanted to prioritise the mother's sleep, which was in line with her treatment plan. Her doctor did not determine she was suffering from postpartum psychosis when she was admitted, but Mr Ryan agreed with medical evidence she likely experienced the condition at her death. The coroner described Ms Skillington, a well-regarded architect, as a remarkable woman and her death as a "tragedy which has devastated her family and friends". "Although the risk of self-harm cannot be completely eliminated for voluntary patients in mental health facilities, patients and families should be able to be confident that they will be appropriately supervised and cared for in a safe environment," Mr Ryan said. Recommendations to the hospital's operator Ramsay Health included tests on its rooms, specific postpartum psychosis training for nursing staff and changes to admission forms. In a statement, Ramsay Health Care offered condolences to Ms Skillington's family and said the findings would be reviewed. "We have offered to meet with her family, if and when they feel ready, should they wish to discuss any aspects of the findings and recommendations," a spokesperson said. Steps have been taken to implement all recommendations from a previous review to ensure safe and effective treatment was provided, they said. Lifeline 13 11 14 beyondblue 1300 22 4636
The Australian
05-06-2025
- Business
- The Australian
EMVision adds Ramsay Health Care boss to board
Ramsay Health Care Australia CEO Carmel Monaghan joins board of EMVision Medical Devices Monaghan has worked across hospital, corporate and global positions at Ramsay for almost three decades Appointment comes as EMVision progresses pivotal trial for emu bedside brain scanner to diagnose stroke Special Report: The CEO of Ramsay Health Care, Australia's largest private hospital operator, has joined the board of EMVision Medical devices as a non-executive director. With her appointment effective today, Carmel Monaghan, who has been CEO of Ramsay Health Care (ASX:RHC) Australia since 2020, joins the board of EMVision Medical Devices (ASX:EMV) at a pivotal time in its commercial journey. Ramsay is Australia's largest private hospital operator and offers a range of multidisciplinary healthcare services. It also has extensive operations internationally including in the UK and Europe. Monaghan has worked across hospital, corporate and global positions at Ramsay for almost three decades. Before her appointment as CEO, Monaghan was group chief of staff of Ramsay's global operations, gaining extensive experience and a comprehensive understanding of healthcare operations and strategy both in Australia and overseas. EMVision said she also served as the group head of marketing and public affairs, driving marketing, brand and communications strategy, during which time the group grew to become a leading private healthcare operator globally. Appointment follows start of pivotal trial Monaghan's appointment comes after the company kicked off a pivotal trial in March for its first commercial device – the emu bedside brain scanner, which is designed to rapidly diagnose stroke at the point-of-care. The pivotal trial supports US Food and Drug Administration (FDA) de novo (new device) clearance for emu. If granted clearance emu is anticipated to become the predicate device for its second device, First Responder, allowing an expedited 510(k) FDA pathway for the pre-hospital market. EMVision this week announced it had broadened the pivotal trial for its first commercial device with activation at Mount Sinai Hospital in New York, scheduled for this month. Mount Sinai is recognised as a leader in stroke research and treatment. Activation of another site – Liverpool Hospital in Sydney, is in progress this Hospital is recognised as one of the largest stroke referral centres in New South Wales. All up, five world-leading hospitals are now taking part in EMVision's pivotal trial with a sixth set to be activated shortly. Watch: EMVision expands trial for bedside stroke scanner A 'transformative opportunity' Monaghan said she looks forward to working with management and fellow directors as the company enters a pivotal phase in its commercialisation journey. 'After more than three decades in healthcare leadership, I'm especially drawn to opportunities where innovation directly addresses unmet patient needs,' she said. 'Stroke and traumatic brain injury are leading causes of global disability and disease burden and will increase with an ageing population. 'Timely access to acute care and treatment are crucial in minimising the impact of stroke and so I'm excited by the transformative opportunity that EMVision's point-of-care neurodiagnostic products represent to improve outcomes for patients.' EMVision chairman John Keep said Monaghan was an 'exceptional addition' to EMVision's board. 'She brings a wealth of experience across clinician engagement, corporate strategy, marketing, procurement and government relations,' he said. 'With our pivotal trial for regulatory clearance underway, the board looks forward to Carmel's contributions as EMVision progresses through to commercialisation and growth.' This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
Yahoo
26-05-2025
- Business
- Yahoo
Ramsay Health Care Limited's (ASX:RHC) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
Ramsay Health Care (ASX:RHC) has had a great run on the share market with its stock up by a significant 8.8% over the last month. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look very promising. Specifically, we decided to study Ramsay Health Care's ROE in this article. ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In simpler terms, it measures the profitability of a company in relation to shareholder's equity. We've discovered 3 warning signs about Ramsay Health Care. View them for free. ROE can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Ramsay Health Care is: 0.5% = AU$29m ÷ AU$5.4b (Based on the trailing twelve months to December 2024). The 'return' is the profit over the last twelve months. One way to conceptualize this is that for each A$1 of shareholders' capital it has, the company made A$0.01 in profit. See our latest analysis for Ramsay Health Care So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics. As you can see, Ramsay Health Care's ROE looks pretty weak. Not just that, even compared to the industry average of 3.0%, the company's ROE is entirely unremarkable. For this reason, Ramsay Health Care's five year net income decline of 17% is not surprising given its lower ROE. We believe that there also might be other aspects that are negatively influencing the company's earnings prospects. For instance, the company has a very high payout ratio, or is faced with competitive pressures. With the industry earnings declining at a rate of 19% in the same period, we deduce that both the company and the industry are shrinking at the same rate. Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. Is Ramsay Health Care fairly valued compared to other companies? These 3 valuation measures might help you decide. Ramsay Health Care's declining earnings is not surprising given how the company is spending most of its profits in paying dividends, judging by its three-year median payout ratio of 85% (or a retention ratio of 15%). With only a little being reinvested into the business, earnings growth would obviously be low or non-existent. Our risks dashboard should have the 3 risks we have identified for Ramsay Health Care. In addition, Ramsay Health Care has been paying dividends over a period of at least ten years suggesting that keeping up dividend payments is way more important to the management even if it comes at the cost of business growth. Existing analyst estimates suggest that the company's future payout ratio is expected to drop to 63% over the next three years. Accordingly, the expected drop in the payout ratio explains the expected increase in the company's ROE to 7.7%, over the same period. Overall, we would be extremely cautious before making any decision on Ramsay Health Care. Because the company is not reinvesting much into the business, and given the low ROE, it's not surprising to see the lack or absence of growth in its earnings. Having said that, looking at current analyst estimates, we found that the company's earnings growth rate is expected to see a huge improvement. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
26-05-2025
- Business
- Yahoo
Ramsay Health Care Limited's (ASX:RHC) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
Ramsay Health Care (ASX:RHC) has had a great run on the share market with its stock up by a significant 8.8% over the last month. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look very promising. Specifically, we decided to study Ramsay Health Care's ROE in this article. ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In simpler terms, it measures the profitability of a company in relation to shareholder's equity. We've discovered 3 warning signs about Ramsay Health Care. View them for free. ROE can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Ramsay Health Care is: 0.5% = AU$29m ÷ AU$5.4b (Based on the trailing twelve months to December 2024). The 'return' is the profit over the last twelve months. One way to conceptualize this is that for each A$1 of shareholders' capital it has, the company made A$0.01 in profit. See our latest analysis for Ramsay Health Care So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics. As you can see, Ramsay Health Care's ROE looks pretty weak. Not just that, even compared to the industry average of 3.0%, the company's ROE is entirely unremarkable. For this reason, Ramsay Health Care's five year net income decline of 17% is not surprising given its lower ROE. We believe that there also might be other aspects that are negatively influencing the company's earnings prospects. For instance, the company has a very high payout ratio, or is faced with competitive pressures. With the industry earnings declining at a rate of 19% in the same period, we deduce that both the company and the industry are shrinking at the same rate. Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. Is Ramsay Health Care fairly valued compared to other companies? These 3 valuation measures might help you decide. Ramsay Health Care's declining earnings is not surprising given how the company is spending most of its profits in paying dividends, judging by its three-year median payout ratio of 85% (or a retention ratio of 15%). With only a little being reinvested into the business, earnings growth would obviously be low or non-existent. Our risks dashboard should have the 3 risks we have identified for Ramsay Health Care. In addition, Ramsay Health Care has been paying dividends over a period of at least ten years suggesting that keeping up dividend payments is way more important to the management even if it comes at the cost of business growth. Existing analyst estimates suggest that the company's future payout ratio is expected to drop to 63% over the next three years. Accordingly, the expected drop in the payout ratio explains the expected increase in the company's ROE to 7.7%, over the same period. Overall, we would be extremely cautious before making any decision on Ramsay Health Care. Because the company is not reinvesting much into the business, and given the low ROE, it's not surprising to see the lack or absence of growth in its earnings. Having said that, looking at current analyst estimates, we found that the company's earnings growth rate is expected to see a huge improvement. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
